What Kind of Drug Is Cannabis? Facts, Classification & Effects Explained

Cannabis is one of the most widely discussed substances in the world, yet genuine confusion about what kind of drug it actually is remains common. Whether you are new to cannabis, returning after a long break, or simply curious about the science behind it, understanding how cannabis is classified, how it interacts with the human body, and what current Canadian regulations say about it is essential. This article provides a factual, educational overview of cannabis drug classification, its effects on the body, and what consumers in Ontario should understand before making informed purchasing decisions at a licensed retailer.

Cannabis Drug Classification: Where Does It Fit?

Cannabis is classified as a psychoactive substance, meaning it contains compounds that interact with brain chemistry and alter perception, mood, or cognition. In Canada, cannabis is a federally regulated substance under the Cannabis Act (S.C. 2018, c. 16), which came into force on October 17, 2018. As of 2026, it remains legal for adults aged 19 and older in Ontario to purchase, possess, and consume cannabis from licensed retailers.

From a pharmacological standpoint, cannabis does not fit neatly into a single drug category. Researchers and pharmacologists typically describe it as a substance with properties spanning multiple classifications depending on dose and individual response. The three most commonly referenced categories in academic literature are:

  • Psychedelic or hallucinogenic: At higher doses, cannabis can produce perceptual distortions, altered time perception, and sensory enhancement.
  • Depressant: Cannabis often produces sedative effects, muscle relaxation, and reduced anxiety at moderate doses, behaviours consistent with central nervous system depressants.
  • Stimulant: Certain cannabis products, particularly those high in THC or specific terpene profiles, can produce elevated heart rate, increased talkativeness, and heightened alertness.

Because cannabis exhibits characteristics from all three categories, many pharmacology texts classify it as a cannabinoid drug: a distinct class defined by its interaction with the body's endocannabinoid system rather than aligning exclusively with depressants, stimulants, or hallucinogens.

The Key Compounds: THC and CBD

Cannabis contains over 100 active chemical compounds called cannabinoids, but two are most significant for consumers to understand: tetrahydrocannabinol (THC) and cannabidiol (CBD).

  • THC (Tetrahydrocannabinol): The primary psychoactive compound in cannabis. THC binds to CB1 receptors in the brain and central nervous system, producing the cognitive and perceptual changes associated with cannabis consumption. Products with higher THC concentrations generally produce more pronounced psychoactive effects.
  • CBD (Cannabidiol): A non-intoxicating cannabinoid that does not produce a "high." CBD interacts with the endocannabinoid system differently from THC and does not bind strongly to CB1 receptors. CBD is available in a wide range of licensed cannabis products in Ontario.

Beyond cannabinoids, cannabis also contains terpenes, aromatic compounds found in many plants, which are believed to contribute to the overall experience of a product through what researchers call the "entourage effect." Common terpenes include myrcene, limonene, caryophyllene, and linalool, each with distinct aromatic and potentially functional characteristics.

For a deeper look at the range of cannabis products available by category, visit the Ashario Cannabis product collections page, which covers flower, edibles, vapes, concentrates, pre-rolls, and more.

Is Cannabis a Strong Drug? Understanding Potency

The question "is cannabis a strong drug?" depends heavily on the product, the individual, the method of consumption, and the dose. As of 2026, licensed cannabis products sold in Ontario dispensaries must clearly display THC and CBD percentages on their packaging, providing consumers with factual information to make informed choices.

Several factors influence the strength of a cannabis experience:

  • THC concentration: Products range from low-THC options (under 10%) to high-potency products (over 25% THC). A first-time consumer and an experienced consumer will respond differently to the same product.
  • Consumption method: Inhalation (smoking or vaping) typically produces effects within minutes, while ingested products such as edibles can take 30 minutes to 2 hours to produce effects and may last significantly longer. This distinction is particularly important for new consumers.
  • Individual biology: Body weight, metabolism, tolerance, prior experience, and individual endocannabinoid system sensitivity all play a role in how cannabis affects a person.
  • Setting and mindset: Environmental and psychological factors can influence how cannabis effects are perceived.

Health Canada and cannabis education bodies consistently recommend that new or infrequent consumers start with low-THC products, use a small amount, and wait to assess effects before consuming more: a principle commonly summarized as "start low, go slow."

How Cannabis Affects the Body

Cannabis affects the body primarily through the endocannabinoid system (ECS), a complex cell-signalling network present in the human body that plays a role in regulating mood, memory, appetite, sleep, and coordination. When cannabinoids from cannabis enter the body, they interact with ECS receptors, primarily CB1 receptors in the brain and CB2 receptors in the immune system, producing a range of effects.

Common short-term effects associated with THC-dominant cannabis products include:

  • Altered perception of time
  • Increased appetite
  • Elevated heart rate
  • Dry mouth
  • Relaxation and reduced tension
  • Heightened sensory experiences
  • Potential for short-term memory impairment at higher doses
  • Anxiety or discomfort in some individuals, particularly at high THC doses

Cannabis is not considered physically addictive in the same way as substances like opioids or alcohol, but regular heavy use can lead to cannabis use disorder in some individuals, characterized by dependence and withdrawal symptoms upon cessation. The Canadian Centre on Substance Use and Addiction (CCSA) provides detailed, evidence-based public resources on this topic.

It is important to note that cannabis sold at licensed dispensaries in Ontario is tested for potency and contaminants. Purchasing from a regulated retailer ensures you receive a product that meets provincial and federal safety standards: a significant distinction from unregulated sources.

Cannabis Facts for Ontario Consumers in 2026

As of 2026, the following facts apply to cannabis consumers in Ontario:

  • The legal age for cannabis purchase and consumption in Ontario is 19 years or older.
  • Adults may legally possess up to 30 grams of dried cannabis (or equivalent) in public.
  • Cannabis can be consumed in private residences and in designated outdoor areas, subject to municipal regulations.
  • Cannabis cannot be consumed in vehicles, workplaces, schools, or within 20 metres of a school or playground.
  • Driving under the influence of cannabis is illegal and subject to serious legal consequences under the Cannabis Act and provincial road safety legislation.
  • All cannabis sold in Ontario must come from federally licensed producers.

Ashario Cannabis operates 4 licensed retail locations across Ontario as of 2026 (in North York (two locations), Aurora, and Thornton) and carries a broad selection of product categories including flower, pre-rolls, edibles, beverages, vapes, concentrates, and accessories. All stores are open daily from 7:00 AM to 11:00 PM, 365 days per year.

To learn more about Ashario's approach to cannabis retail and education, visit the About Ashario Cannabis page, or explore the Ashario Cannabis blog for additional educational articles.

Frequently Asked Questions About Cannabis Drug Classification

What kind of drug is cannabis scientifically?

Scientifically, cannabis is classified as a cannabinoid drug: a substance that produces its primary effects by interacting with the body's endocannabinoid system. It exhibits properties of depressants, stimulants, and hallucinogens depending on dose and product type, which is why it does not fit cleanly into a single traditional drug category. The main psychoactive compound responsible for intoxication is THC (tetrahydrocannabinol).

Is cannabis legal in Ontario, Canada?

Yes. As of 2026, cannabis is legal for adults aged 19 and older in Ontario under Canada's Cannabis Act (2018). Adults can legally purchase cannabis from licensed retailers such as Ashario Cannabis, which operates four locations across Ontario including North York, Aurora, and Thornton. Public possession is limited to 30 grams of dried cannabis or the equivalent.

What is the difference between THC and CBD in cannabis?

THC (tetrahydrocannabinol) is the primary psychoactive compound in cannabis and is responsible for the intoxicating effects associated with cannabis consumption. CBD (cannabidiol) is a non-intoxicating cannabinoid that does not produce a high. Both compounds interact with the endocannabinoid system but in different ways. Licensed cannabis products in Ontario must display their THC and CBD concentrations on the label, making it easier for consumers to choose products that match their preferences.

How long do cannabis effects last?

The duration of cannabis effects varies significantly based on the consumption method. When cannabis is inhaled (smoked or vaped), effects typically begin within minutes and can last between 1 and 3 hours. When cannabis is consumed as an edible or beverage, onset can take anywhere from 30 minutes to 2 hours, and effects can last 4 to 8 hours or longer. Individual factors including tolerance, metabolism, and the specific product consumed all influence duration.

Where can I buy cannabis legally in North York, Aurora, or Thornton, Ontario?

Ashario Cannabis operates four licensed retail dispensaries in Ontario, all open daily from 7:00 AM to 11:00 PM. Locations include two North York stores: one at 1111A Finch Ave W Unit 1 (Finch & Dufferin) and one at 6464 Yonge St Unit #187 (Centerpoint Mall), as well as locations in Aurora at 15114 Yonge St and Thornton at 239 Barrie St. For a full list of addresses and contact details, visit the Ashario store locations page.

Visit Ashario Cannabis at Any of Our Four Ontario Locations

Ashario Cannabis is committed to providing Ontario consumers with accurate information, a knowledgeable staff, and a broad product selection across all four licensed store locations. Whether you are exploring cannabis for the first time or looking to deepen your understanding of the products available to you, Ashario's team is available to answer your questions in a judgment-free environment.

All Ashario Cannabis locations are open every day of the year from 7:00 AM to 11:00 PM. Here is a quick reference for all four stores:

  • Ashario Cannabis: Finch & Dufferin: 1111A Finch Ave W Unit 1, North York, ON M3J 2P7 | +1-647-368-7722
  • Ashario Cannabis: Centerpoint Mall: 6464 Yonge St Unit #187, North York, ON M2M 3X4 | +1-416-477-9333
  • Ashario Cannabis: Aurora: 15114 Yonge St, Aurora, ON L4G 1M2 | +1-905-503-6770
  • Ashario Cannabis: Thornton: 239 Barrie St, Thornton, ON L0L 2N0 | +1-249-733-9333

Have a question before you visit? Reach the Ashario team through the Ashario Cannabis contact page, or browse all available product categories at www.ashario.com.

Ashario Cannabis: Licensed Cannabis Retailer in Ontario, Canada. Open daily 7:00 AM to 11:00 PM at four locations: North York (Finch & Dufferin), North York (Centerpoint Mall), Aurora, and Thornton. All content is intended for adults aged 19 and older. This article is for educational purposes only and does not constitute medical advice.

Important Notice: Content on this website is intended strictly for informational purposes. Ashario does not promote any product or represent that the products mentioned on Ashario's website are treatments for any kind of medical condition. Ashario cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Ashario does not endorse any user-reported information, any particular strain, product, producer, organization, treatment, or therapy.